CONTROL OF OSTEOGENESIS AND ADIPOGENESIS BY EBF

EBF 对成骨和脂肪生成的控制

基本信息

  • 批准号:
    7913053
  • 负责人:
  • 金额:
    $ 30.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Osteoblasts, the cells that form bone, are mesenchymal in origin and like other mesenchymal lineages arise from pluripotential stem cells through a series of developmental transitions. The osteoblast developmental pathway is only partially understood, particularly in its early stages, where little is know about the cell fate decisions that lead to commitment to the osteoblast lineage. Adipocytes, the cells that produce fat, likely share a common early progenitor with osteoblasts, although little is known about the molecular control of this lineage bifurcation. Growing evidence indicates that transcription factors required for B lymphocyte development from hematopoietic stem cells are critical for proper skeletal development although as yet none have been implicated in osteoblast differentiation. We have discovered that Early B Cell Factor-1 (EBF-1), a transcription factor essential for B cell development, is expressed in osteoblasts and plays a critical role in controlling osteoblast development. EBF-1 deficient mice are runted, have increased bone formation parameters, and display a striking increase in numbers of osteoblasts. Remarkably, these mice also exhibit a dramatic expansion of adipocytes in the medullary canal of long bones. The central hypothesis underlying this proposal is that EBF-1 and its upstream regulatory and downstream target genes are critical for the control of osteoblast and adipocyte development. Our findings suggest that EBF-1 and EBF-1 deficient mice provide a unique opportunity to gain significant molecular insight into the development of these two lineages. The long-term goal of our work is to identify the mechanism(s) by which EBF-1 regulates osteogenesis and adipogenesis. The first step in achieving this goal is a careful analysis of the EBF-1 deficient mice at the histological, morphological, cellular, and molecular level, which will provide the information needed to formulate detailed molecular hypotheses for the role of EBF-1 in bone and fat cell development. Toward this end, we will pursue two Specific Aims: 1) To determine the bone phenotype of EBF-1 deficient mice; and 2) To characterize through a quantitative analysis the functional and molecular properties of EBF-1 deficient osteoblasts, osteoblast precursors, and adipocytes. We anticipate that these experiments will lead to new models for osteoblast development and hence for the potential to discover new anabolic pathways. Such information would be applicable to a wide variety of skeletal defects including age-related osteopenia, post-menopausal osteoporosis, fracture repair, and extended survival of prosthetic implants.
描述(由申请人提供):成骨细胞,即形成骨骼的细胞,起源于间充质,并且像其他间充质谱系一样,由多能干细胞通过一系列发育转变产生。成骨细胞发育途径仅被部分了解,特别是在其早期阶段,人们对导致成骨细胞谱系定型的细胞命运决定知之甚少。脂肪细胞(产生脂肪的细胞)可能与成骨细胞共享一个共同的早期祖细胞,尽管人们对这种谱系分叉的分子控制知之甚少。越来越多的证据表明,造血干细胞发育成 B 淋巴细胞所需的转录因子对于骨骼的正常发育至关重要,尽管迄今为止尚未发现与成骨细胞分化有关的转录因子。我们发现早期 B 细胞因子-1 (EBF-1) 是 B 细胞发育必需的转录因子,在成骨细胞中表达,在控制成骨细胞发育中发挥着关键作用。 EBF-1缺陷小鼠身材矮小,骨形成参数增加,并且成骨细胞数量显着增加。值得注意的是,这些小鼠的长骨髓管中的脂肪细胞也出现了显着的扩张。该提议的核心假设是 EBF-1 及其上游调节基因和下游靶基因对于控制成骨细胞和脂肪细胞的发育至关重要。我们的研究结果表明 EBF-1 和 EBF-1 缺陷小鼠提供了独特的机会来获得对这两个谱系发育的重要分子洞察。我们工作的长期目标是确定 EBF-1 调节成骨和脂肪生成的机制。实现这一目标的第一步是在组织学、形态学、细胞和分子水平上对 EBF-1 缺陷小鼠进行仔细分析,这将为制定 EBF-1 在骨中作用的详细分子假设提供所需的信息。和脂肪细胞的发育。为此,我们将追求两个具体目标:1)确定EBF-1缺陷小鼠的骨表型; 2) 通过定量分析表征 EBF-1 缺陷的成骨细胞、成骨细胞前体和脂肪细胞的功能和分子特性。我们预计这些实验将带来成骨细胞发育的新模型,从而有可能发现新的合成代谢途径。这些信息适用于各种骨骼缺陷,包括与年龄相关的骨质减少、绝经后骨质疏松症、骨折修复和延长假体植入物的存活期。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK C HOROWITZ其他文献

MARK C HOROWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK C HOROWITZ', 18)}}的其他基金

The Sixth International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems
第六届国际骨免疫学会议:免疫与骨骼系统的相互作用
  • 批准号:
    9117878
  • 财政年份:
    2016
  • 资助金额:
    $ 30.79万
  • 项目类别:
The Fifth International Conference on Osteoimmunology: Interactions of the Immune
第五届国际骨免疫学会议:免疫的相互作用
  • 批准号:
    8709156
  • 财政年份:
    2014
  • 资助金额:
    $ 30.79万
  • 项目类别:
Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine
新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动
  • 批准号:
    8692538
  • 财政年份:
    2013
  • 资助金额:
    $ 30.79万
  • 项目类别:
Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine
新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动
  • 批准号:
    8581522
  • 财政年份:
    2013
  • 资助金额:
    $ 30.79万
  • 项目类别:
CELL CORE
细胞核心
  • 批准号:
    8376753
  • 财政年份:
    2012
  • 资助金额:
    $ 30.79万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8328698
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8698743
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8496032
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance
骨髓肥胖、矿物质代谢和能量平衡的跨学科研究
  • 批准号:
    9769004
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8183483
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:

相似海外基金

Mechanisms Driving Enhanced Susceptibility of Females versus Males to High-Fat Diet-Induced Increases in High Blood Pressure
女性与男性相比,对高脂肪饮食引起的高血压的易感性增强的机制
  • 批准号:
    10714531
  • 财政年份:
    2023
  • 资助金额:
    $ 30.79万
  • 项目类别:
Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss
衰老对前 B 细胞产物 α5 的影响及其对与年龄相关的骨质流失的贡献
  • 批准号:
    10589513
  • 财政年份:
    2022
  • 资助金额:
    $ 30.79万
  • 项目类别:
Mechanisms of metabolic dysfunction in the offspring of maternal obesity: role of inflammation
母亲肥胖后代代谢功能障碍的机制:炎症的作用
  • 批准号:
    9807710
  • 财政年份:
    2019
  • 资助金额:
    $ 30.79万
  • 项目类别:
Mechanisms of metabolic dysfunction in the offspring of maternal obesity: role of inflammation
母亲肥胖后代代谢功能障碍的机制:炎症的作用
  • 批准号:
    10006018
  • 财政年份:
    2019
  • 资助金额:
    $ 30.79万
  • 项目类别:
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and Atherosclerosis
Interleukin12/STAT4 通路在胰岛素抵抗和动脉粥样硬化中的作用
  • 批准号:
    8258687
  • 财政年份:
    2011
  • 资助金额:
    $ 30.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了